Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
White polyester film and surface light source therewith
Systems and methods for sensing external magnetic fields in implantable medical devices
System and method for efficient resource management of a signal flow programmed digital signal processor code
System for seeking for an optimal configuration of a bi-, tri- or multi-ventricular cardiac resynchronization implanted device
Soybean cultivar BY0811143
Medicament delivery device and a method of medicament delivery
  Randomly Featured Patents
Apparatus to concentrate solutions and to recover solvents
Light source device, method for manufacturing light source device, and projection type display apparatus
Method for forming an abrasion resistant coating from cellulose ester and pentaerythritol acrylates
Separation of diamond from gangue minerals
Direction selection mechanism for analytical tool, and analytical device
Golf cart wheel cleaner
Braking force control device for vehicle
Method for secure installation of device in packet based communication network
Method of and apparatus for generating image data representing integrated image
Device and method of fail-safe control for electronically controlled automatic transmission